C֌W

n_ ތ^ 75%l Nϒl
COD  H  DO COD 咰یQ n-wLT
o
Sf S
(mg/L)   (mg/L) (mg/L) (MPN/100ml) (mg/L) (mg/L) (mg/L)
䥑哇 ND-3 B U 2 8.2 8.2 1.8   <0.5 0.13 0.019
ND-4 A U 1.8 8.2 8.1 1.7 1.5E+01   0.13 0.019
ND-5 A U 1.9 8.2 8.2 1.7 4.5E+01   0.13 0.019
ND-6 A U 1.9 8.2 8.3 1.7 1.0E+01   0.11 0.016
ND-7 A U 1.7 8.2 8.4 1.6 3.1E+00   0.12 0.016
ND-8 A U 1.9 8.2 8.2 1.7 5.6E+00   0.12 0.017
ND-9 B U 2 8.2 8 1.8   <0.5 0.12 0.019
AD-1 A U 2.1 8.2 8.5 1.9 3.2E+00   0.12 0.016
AD-2 B U 2.1 8.2 8.5 1.7     0.12 0.016
AD-3 B U 2.6 8.2 8.7 2.9   <0.5 0.27 0.033
AD-4 B U 2.9 8.2 8.6 2.7   <0.5 0.25 0.032
AD-5 A U 1.8 8.2 8.4 1.7 2.0E+00   0.11 0.015

n}ɖ߂

 

͐֌W

n_ ތ^ 75%l Nϒl
BOD  H  DO BOD SS 咰یQ
(mg/L)   (mg/L) (mg/L) (mg/L) (MPN/100ml)
RF PC-1(Ђ) A 0.6 7.7 10 0.6 3 2.7E+04
PC-2(ϑP) A 0.5 7.9 11 0.6 3 1.7E+04
NC-2(܋) A 1.3 7.6 11 1.1 6 2.6E+04
NC-1(勴) B 1 7.9 10 1 9 1.9E+04
NC-4() A 2.2 7.3 8.9 2.1 8 8.9E+04
NC-3(czC؋) B 1.9 7.4 9.1 1.8 9 5.4E+04
cz{ AC-2() A   7.7 11 0.9 6 2.4E+04
AC-1(C) B 1.1 7.8 9.9 0.9 10 3.0E+04

n}ɖ߂